Related Experiment Video
Updated: May 24, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Seroepidemiology of hepatitis a in the croatian population
Tatjana Vilibic-Cavlek1, Jasmina Kucinar, Suncanica Ljubin-Sternak
1Department of Virology, Croatian national Institute of public Health, Zagreb and School of Medicine University of Zagreb, Zagreb, Croatia.
Background:
Hepatitis A virus (HAV) has a worldwide distribution, although this distribution tends to be uneven among geographical regions and population groups. The prevalence of anti-HAV antibodies in the general population varies widely among countries. In Europe, the seroprevalence of HAV is reported to range from 32% to 88%.
Objectives:
The aim of this study was to determine the seroprevalence of HAV among the general Croatian population.
Materials And Methods:
During a 2-year period (2008-2009), a total of 791 serum samples were tested for the presence of anti-HAV total (IgM+IgG) and anti-HAV IgM antibodies using an automated enzyme-linked fluorescent assay (Mini Vidas; bioMérieux, Marcy l'Etoile, France).
Results:
The overall anti-HAV seroprevalence was 41.6%. The observed difference in the seroprevalence rates among male and female patients was not statistically significant (44% vs. 39.6%, P = 0.218). A marked increase in anti-HAV seropositivity with age was observed (P < 0.001). The seroprevalence did not differ significantly between participants residing in rural regions (45.3%) and those residing in urban regions (40.6%, P = 0.292).
Conclusions:
Our results corroborate those of seroprevalence studies in other developed countries. More than half of the Croatian population (59.4%) is susceptible to HAV infection. Older age is an important predictor for being anti-HAV positive.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Infectious Diseases and Their Occurrence
Investigation of Disease Outbreaks
Bias in Epidemiological Studies
Bacterial Gastroenteritis
